Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS | 9 | 49 | -5,35 % | ||
TANGO THERAPEUTICS | 8 | 8 | 0,00 % | ||
FUSION PHARMACEUTICALS | 7 | 7 | 0,00 % | ||
BIONTECH | 6 | 35 | +0,45 % | ||
BLUEBIRD BIO | 6 | 7 | +1,23 % | ||
MIRUM PHARMACEUTICALS | 5 | 15 | +0,83 % | ||
ARVINAS | 5 | 5 | 0,00 % | ||
ALPINE IMMUNE SCIENCES | 4 | 4 | -0,61 % | ||
CUREVAC | 3 | 18 | -0,17 % | ||
ARCELLX | 3 | 4 | 0,00 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10:02 | TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion | 1 | Alliance News | ||
09:50 | AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion | 2 | BNN Bloomberg | ||
09:43 | BRISANTE Meldung setzt Novavax Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | Felix Haupt | |||
09:39 | Pharmakonzern Astrazeneca will Onkologie-Spezialisten Fusion übernehmen | 28 | dpa-AFX | CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca will den kanadischen Krebsspezialisten Fusion Pharmaceuticals übernehmen. Dabei wolle der britisch-schwedische Hersteller je 21 Dollar in bar pro... ► Artikel lesen | |
09:30 | Baird starts Axsome Therapeutics stock at Outperform on promising trial outlook | 2 | Investing.com | ||
09:22 | AstraZeneca to buy Amolyt Pharma | 2 | POST Online Media | ||
09:18 | Baird bullish on Alkermes stock, starts with Outperform on strong pipeline | 1 | Investing.com | ||
09:18 | Madrigal Pharmaceuticals upsizes public offering to $600 million | 2 | Investing.com | ||
09:18 | AstraZeneca will buy Fusion Pharmaceuticals for ~$2B | 3 | Seeking Alpha | ||
09:04 | Astrazeneca kauft Fusion Pharma für mindestens 2 Milliarden Dollar | 131 | Dow Jones News | DJ Astrazeneca kauft Fusion Pharma für mindestens 2 Milliarden Dollar
Von Ian Walker
LONDON (Dow Jones)--Astrazeneca erwirbt Fusion Pharmaceuticals. Der Kaufpreis belaufe sich auf zunächst... ► Artikel lesen | |
08:53 | AstraZeneca to buy Fusion Pharmaceuticals, Diageo names Sir John Manzoni as next chair | 4 | Sharecast | ||
08:53 | AstraZeneca to buy US-listed Fusion Phrama for $2bn | 3 | Sharecast | ||
08:42 | AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln | 125 | AFX News | LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that it has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. (FUSN) in about $2.4... ► Artikel lesen | |
08:34 | AstraZeneca to buy Fusion Pharma for $2 billion in cash | 5 | Reuters | ||
08:09 | AstraZeneca to acquire Fusion | 4 | Cision News | ||
08:00 | Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer | 30 | PR Newswire | Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities
Fusion shareholders... ► Artikel lesen | |
07:24 | Arvinas gets new chief medical head | 1 | Seeking Alpha | ||
07:00 | AstraZeneca PLC - AstraZeneca to acquire Fusion | 1 | Regulatory News Services (RNS) | ||
05:10 | Jetzt aufpassen - 100 % Performance möglich mit BioNTech, Bayer, Cardiol Therapeutics oder HelloFresh | 769 | inv3st.de | Für Investoren im BioTech-Sektor startet das Jahr 2024, wie das vorherige geendet hat. Man wartet auf den Big Bang, der sich noch nicht so recht einstellen möchte. Doch wo es keine Pandemie mehr gibt... ► Artikel lesen | |
05:06 | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering | 10 | GlobeNewswire (USA) |